Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Interim data reported from ongoing phase Ib study of EDP-1815 in psoriasis

Aug. 7, 2019

Complete wound healing reported in first patient treated in phase II study of RGN-137

Aug. 6, 2019

Sanofi reports updates for Dupixent as treatment in adolescents and children with atopic dermatitis

Aug. 6, 2019

Lifesci Pharmaceuticals divulges KLKB1 inhibitors

Aug. 2, 2019

Phase II study of ATI-501 in alopecia areata meets primary endpoint

July 31, 2019

Activation of neuronal TRPV1 is sufficient to cause the equivalent of psoriasis

July 26, 2019

Arcutis reports promising topline phase IIb data on ARQ-151 for plaque psoriasis

July 23, 2019

Swedish MPA approves first-in-human trial of ILP-100

July 22, 2019

Affibody completes 12-week interim analysis of phase II psoriasis study of ABY-035

July 17, 2019

Galderma describes new mTOR inhibitors

July 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...